Article
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Jul 2010
Ferrara Felicetto, Izzo Tiziana, Criscuolo Clelia, Riccardi Cira, Muccioli Giada, Viola Assunta, Pane Fabrizio, Palmieri Salvatore
Abstract excerpt
Mutations of the nucleophosmin gene (NPM1), in the absence of concurrent FLT3-internal tandem duplication (FLT3-ITD) have impressive prognostic value in patients with acute myelogenous leukemia (AML), carrying normal karyotype (NK). In this study we describe treatment results from a series of 19...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.